Evidence map›Paper›PMID 41010965›Full record

ArticleMedicina (Kaunas, Lithuania)2025

Prognostic Impact of Glomerular Filtration Rate Decline on Survival Outcomes in Metastatic Renal Cell Carcinoma Treated with Targeted Therapy.

Oktay Halit Aktepe, Ahmet Melih Arslan, Ozge Yetginoglu, Hatice Altas, Canberk Sencan, Mehmet Sinan Akarca, Hasan Cagri Yildirim, Huseyin Salih Semiz, Ilkay Tugba Unek, Aziz Karaoglu and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Oktay Halit AktepeDepartment of Medical Oncology, Dokuz Eylul University, Izmir 35330, Turkey.ORCID 0000-0003-3540-0701
Ahmet Melih ArslanDepartment of Medical Oncology, Dokuz Eylul University, Izmir 35330, Turkey.ORCID 0000-0002-6126-4611
Ozge YetginogluDepartment of Medical Oncology, Dokuz Eylul University, Izmir 35330, Turkey.
Hatice AltasDepartment of Internal Medicine, Dokuz Eylul University, Izmir 35330, Turkey.
Canberk SencanDepartment of Medical Oncology, Dokuz Eylul University, Izmir 35330, Turkey.
Mehmet Sinan AkarcaDepartment of Medical Oncology, Dokuz Eylul University, Izmir 35330, Turkey.
Hasan Cagri YildirimDepartment of Medical Oncology, Ege University, Izmir 35100, Turkey.ORCID 0000-0003-3060-377X
Huseyin Salih SemizDepartment of Medical Oncology, Dokuz Eylul University, Izmir 35330, Turkey.
Ilkay Tugba UnekDepartment of Medical Oncology, Dokuz Eylul University, Izmir 35330, Turkey.
Aziz KaraogluDepartment of Medical Oncology, Dokuz Eylul University, Izmir 35330, Turkey.
Mustafa ErmanDepartment of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey.
Suayib YalcinDepartment of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Renal CellGlomerular Filtration RateKidney NeoplasmsMolecular Targeted TherapyAdultAgedCohort StudiesFemaleHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisProportional Hazards ModelsRetrospective StudiesTurkeyglomerular filtration ratemetastatic renal cell carcinomaprognosistargeted therapy

Identifiers

PMID41010965
PMCPMC12471626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.